BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29274785)

  • 21. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
    Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells.
    Basaki Y; Hosoi F; Oda Y; Fotovati A; Maruyama Y; Oie S; Ono M; Izumi H; Kohno K; Sakai K; Shimoyama T; Nishio K; Kuwano M
    Oncogene; 2007 Apr; 26(19):2736-46. PubMed ID: 17072343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Extracellular Y-box binding protein-1 promotes proliferation and metastasis of HepG2 cells through Notch3 receptor].
    Shi J; Li P; Zou L; Chen P; Zhang LP
    Zhonghua Gan Zang Bing Za Zhi; 2016 Mar; 24(3):202-6. PubMed ID: 27095764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of indirubin and 2,3,7,8-tetrachlorodibenzo-p-dioxin on the aryl hydrocarbon receptor (AhR) signalling in liver progenitor cells.
    Procházková J; Kozubík A; Machala M; Vondráček J
    Toxicology; 2011 Jan; 279(1-3):146-54. PubMed ID: 20951181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indirubin-3'-oxime prevents hepatic I/R damage by inhibiting GSK-3beta and mitochondrial permeability transition.
    Varela AT; Simões AM; Teodoro JS; Duarte FV; Gomes AP; Palmeira CM; Rolo AP
    Mitochondrion; 2010 Aug; 10(5):456-63. PubMed ID: 20433952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Transcription Induces Phosphorylation of YB-1 at Ser102 and Its Accumulation in the Nucleus.
    Kretov DA; Mordovkina DA; Eliseeva IA; Lyabin DN; Polyakov DN; Joshi V; Desforges B; Hamon L; Lavrik OI; Pastré D; Curmi PA; Ovchinnikov LP
    Cells; 2019 Dec; 9(1):. PubMed ID: 31906126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YB-1 Phosphorylation at Serine 209 Inhibits Its Nuclear Translocation.
    Sogorina EM; Kim ER; Sorokin AV; Lyabin DN; Ovchinnikov LP; Mordovkina DA; Eliseeva IA
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indirubin-3-Oxime Effectively Prevents 6OHDA-Induced Neurotoxicity in PC12 Cells via Activating MEF2D Through the Inhibition of GSK3β.
    Hu S; Cui W; Zhang Z; Mak S; Xu D; Li G; Hu Y; Wang Y; Lee M; Tsim KW; Han Y
    J Mol Neurosci; 2015 Dec; 57(4):561-70. PubMed ID: 26346600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling.
    Lee S; Lee M; Kim JB; Jo A; Cho EJ; Yu SJ; Lee JH; Yoon JH; Kim YJ
    Biochem Biophys Res Commun; 2016 May; 473(4):1247-1254. PubMed ID: 27091428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines.
    Qian JQ; Sun P; Pan ZY; Fang ZZ
    Int J Clin Exp Pathol; 2015; 8(9):11934-44. PubMed ID: 26617951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic markers of hepatocellular carcinoma.
    Yasen M; Kajino K; Kano S; Tobita H; Yamamoto J; Uchiumi T; Kon S; Maeda M; Obulhasim G; Arii S; Hino O
    Clin Cancer Res; 2005 Oct; 11(20):7354-61. PubMed ID: 16243807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma.
    Bagi CM; Gebhard DF; Andresen CJ
    Eur J Gastroenterol Hepatol; 2012 May; 24(5):563-74. PubMed ID: 22314934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of a DNA binding protein, MDR-NF1/YB-1, in human MDR1 gene expression by actinomycin D.
    Asakuno K; Kohno K; Uchiumi T; Kubo T; Sato S; Isono M; Kuwano M
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1428-35. PubMed ID: 7908518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
    Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
    Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of cytotoxic and pro-apoptotic effects of 2-aminophenoxazine-3-one on the rat hepatocellular carcinoma cell line dRLh-84, the human hepatocellular carcinoma cell line HepG2, and the rat normal hepatocellular cell line RLN-10 in combination with 2-deoxy-D-glucose.
    Takemura A; Che XF; Tabuchi T; Moriya S; Miyazawa K; Tomoda A
    Oncol Rep; 2012 Feb; 27(2):347-55. PubMed ID: 22076586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpressed nuclear BAG-1 in human hepatocellular carcinoma is associated with poor prognosis and resistance to doxorubicin.
    Ni W; Chen B; Zhou G; Lu C; Xiao M; Guan C; Zhang Y; He S; Shen A; Ni R
    J Cell Biochem; 2013 Sep; 114(9):2120-30. PubMed ID: 23553841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
    Jia H; Yang Q; Wang T; Cao Y; Jiang QY; Ma HD; Sun HW; Hou MX; Yang YP; Feng F
    Biochim Biophys Acta; 2016 Jul; 1860(7):1417-30. PubMed ID: 27091611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
    Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
    BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of BCRP expression and restoration of sensitivity to chemotherapy in multidrug-resistant HCC cell line HEPG2/ADM by RNA interference.
    Li H; Zhou S; Li T; Liu Z; Wu J; Zeng G; Liu C; Gong J
    Hepatogastroenterology; 2012 Oct; 59(119):2238-42. PubMed ID: 23435138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.